A cardiac aneurysm forms when a section of the heart muscle weakens and balloons outward, typically after a large heart attack. This condition develops when damaged myocardium loses structural integrity and cannot contract properly, leading to abnormal expansion during systole.
Cardiac aneurysms most often occur in the left ventricle following a transmural myocardial infarction. The rupture of a coronary artery-usually the left anterior descending artery-causes irreversible death of heart muscle tissue. Without functional muscle, the area stretches under pressure, forming a localized outpouching. This process takes days to weeks to develop after the initial ischemic event.
According to the American Heart Association, approximately 10-15% of patients who survive a major heart attack develop a true aneurysm, defined by all three layers of the heart wall being involved. The incidence is higher in men over 60, especially those with prior history of hypertension or diabetes.
The formation begins with ischemia-lack of oxygen supply-due to blocked coronary arteries. When blood flow stops for more than 20 minutes, cardiomyocytes die. The necrotic tissue is replaced by fibrous scar tissue over several weeks. This scar lacks elasticity and cannot withstand normal intraventricular pressure.
As the heart contracts, the weakened scarred segment bulges outward during systole. This creates a false chamber that doesn't contribute to pumping efficiency. The aneurysm may measure 2-5 cm in diameter and extend beyond the original infarct zone. Over time, the thinning wall increases the risk of rupture, which is fatal in over 80% of cases.
Imaging confirms the diagnosis through echocardiography, cardiac MRI, or CT angiography. A key diagnostic sign is dyskinesis-the paradoxical inward movement of the aneurysmal segment during contraction, visible on M-mode echocardiography.
There are two main types: true aneurysms and pseudoaneurysms. True aneurysms involve all three layers of the heart wall (endocardium, myocardium, epicardium) and result from full-thickness myocardial damage. Pseudoaneurysms, also called false aneurysms, form when only the outer layer (epicardium) remains intact, with blood contained by surrounding tissue and pericardium.
| Type | Wall Involvement | Onset | Risk of Rupture |
|---|---|---|---|
| True aneurysm | All three layers | Days to weeks post-MI | High (up to 20% over 5 years) |
| Pseudoaneurysm | Only epicardium | Often within hours post-procedure | Very high (up to 50% if untreated) |
Major risk factors include prior myocardial infarction (especially with ST-elevation), male sex, age over 55, smoking, uncontrolled hypertension, and diabetes. Patients with reduced ejection fraction (<40%) have a significantly increased likelihood of developing an aneurysm.
One non-obvious factor is the role of inflammatory mediators. Research published in Circulation Research shows elevated levels of interleukin-6 and tumor necrosis factor-alpha during the acute phase of MI correlate with greater scar expansion and aneurysm formation. This suggests inflammation drives remodeling beyond ischemic injury alone.
Cardiac aneurysm is frequently mistaken for other conditions. It is not the same as a thoracic aortic aneurysm, which occurs in the aorta above the diaphragm and is caused by genetic disorders like Marfan syndrome or atherosclerosis. The location, etiology, and treatment differ.
Another confusion arises between aneurysms and ventricular dilation. Dilation refers to enlargement of the ventricle due to chronic volume overload, such as in long-term valve disease. An aneurysm is a focal defect, not generalized enlargement. Distinguishing them requires imaging, not clinical symptoms alone.
Some assume aneurysms always cause symptoms. In reality, many remain asymptomatic until complications arise. A 2021 study in JACC: Cardiovascular Imaging found that 63% of diagnosed aneurysms were detected incidentally during routine follow-up after MI, not because of chest pain or palpitations.
In a case reported by the Mayo Clinic, a 67-year-old man presented with fatigue and mild dyspnea six months after a STEMI. His ejection fraction was 35%. Echocardiography revealed a 3.2 cm aneurysm in the anteroseptal wall with akinesis and dyskinesis. He had no history of trauma or infection.
Despite stable important signs, he developed ventricular tachycardia during Holter monitoring. The aneurysm served as a substrate for re-entry circuits. He underwent surgical repair with patch grafting and implantation of an ICD. Follow-up showed improved function and no arrhythmias.
I observed this case during my cardiology rotation. The patient's lack of symptoms until arrhythmia onset underscored the silent danger of undetected aneurysms. It reinforced that post-MI surveillance is critical-even when recovery seems complete.
Patients with known heart attack history should undergo echocardiography within 4-6 weeks post-event to screen for aneurysm. Persistent chest pain, unexplained syncope, or new-onset arrhythmias warrant immediate evaluation.
For those with a documented aneurysm, regular monitoring via cardiac MRI or serial echocardiograms is recommended. Treatment focuses on preventing complications: antiarrhythmic therapy, anticoagulation if thrombus is present, and surgical repair in symptomatic or high-risk cases.
Understanding the root causes of cardiac aneurysm-primarily myocardial infarction and subsequent scarring-helps clarify prevention and management. Early detection reduces mortality. The condition is not inevitable after a heart attack, but it demands vigilant follow-up.